Department of Radiology, Duke University Medical Center, Erwin Rd, Box 3808, Durham, NC 27710, USA.
AJR Am J Roentgenol. 2011 Sep;197(3):W445-51. doi: 10.2214/AJR.10.6154.
The purpose of this article is to assess whether iopamidol-370 provides superior vascular contrast of the coronaries and depiction of anatomic detail without affecting heart rate and beat-to-beat variability during coronary dual-source MDCT compared with iodixanol-320.
In this prospective trial, coronary CT angiography was performed on 60 adult patients using either iopamidol-370 or iodixanol-320. Cohorts were matched by age, habitus, sex, and baseline heart rate, with cohort sizes determined by power analysis. All studies were performed on a dual-source MDCT scanner with retrospective ECG-gating utilizing automatic pitch adjustment. Data assessment focused on heart rate variability during contrast administration statistically evaluated as Student t test comparisons within and between cohorts, coronary contrast-to-noise ratio analysis of the main coronary arteries utilizing Student t test comparisons between cohorts, and coronary branch depiction and distribution analysis in dual-reader consensus decisions between cohorts.
Thirty patients matched for age, habitus, sex, and heart rate were evaluated in each cohort. ECG analyses found a statistically significant (p = 0.013) decrease in heart rate during administration of iodixanol-320. Beat-to-beat variations, expressed as coefficient of variation, within and among cohorts were low (coefficient of variation, < 0.05). Contrast-to-noise ratio was significantly increased for iopamidol-370 versus iodixanol-320 (aortic root, p = 0.021; left main, p = 0.032; left anterior descending, p = 0.033; left circumflex, p = 0.039; and right, p = 0.009). Analysis of coronary branch visualization revealed improved depiction for iopamidol-370 compared with iodixanol-320.
Iopamidol-370, with its higher iodine concentration, provided greater vascular contrast of the arterial coronary tree and improved depiction of anatomic detail without significantly impacting cardiac heart rate during coronary MDCT imaging, as compared with iodixanol-320.
本文旨在评估与碘克沙醇 320 相比,碘帕醇 370 用于冠状动脉双源 MDCT 时,在不影响心率和心率变异性的情况下,是否能提供更好的冠状动脉血管对比度和解剖细节显示。
在这项前瞻性试验中,60 例成年患者分别使用碘帕醇 370 或碘克沙醇 320 进行冠状动脉 CT 血管造影。通过年龄、体型、性别和基础心率匹配队列,根据功效分析确定队列大小。所有研究均在双源 MDCT 扫描仪上进行,采用回顾性 ECG 门控和自动螺距调整。数据评估侧重于对比剂给药期间的心率变异性,通过组内和组间学生 t 检验比较进行统计学评估,通过组间学生 t 检验比较对主冠状动脉的对比噪声比进行分析,通过组间双读者共识决策对冠状动脉分支显示和分布进行分析。
在每个队列中均评估了 30 例年龄、体型、性别和心率匹配的患者。ECG 分析发现,碘克沙醇 320 给药期间心率有统计学显著(p = 0.013)下降。组内和组间的心率变异性(以变异系数表示)均较低(变异系数 < 0.05)。与碘克沙醇 320 相比,碘帕醇 370 的对比噪声比显著增加(主动脉根部,p = 0.021;左主干,p = 0.032;左前降支,p = 0.033;左旋支,p = 0.039;右冠状动脉,p = 0.009)。冠状动脉分支可视化分析显示,碘帕醇 370 较碘克沙醇 320 改善了分支显示。
与碘克沙醇 320 相比,高碘浓度的碘帕醇 370 在不显著影响冠状动脉 MDCT 成像中心率的情况下,提供了更好的冠状动脉树血管对比度和解剖细节显示。